Janney Montgomery Scott LLC Oncocyte Corp Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 01, 2019
SELL
$1.38 - $2.59 $136 - $256
-99 Reduced 0.81%
12,066 $17,000
Q3 2018

Nov 05, 2018
BUY
$2.2 - $3.45 $270 - $424
123 Added 1.02%
12,165 $30,000
Q2 2018

Jul 24, 2018
SELL
$2.0 - $3.3 $2,000 - $3,300
-1,000 Reduced 7.67%
12,042 $31,000
Q1 2018

Apr 19, 2018
BUY
$1.25 - $4.6 $16,302 - $59,993
13,042 New
13,042 $27,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
411K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $326M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email